M Solis1, A Velay1, P Gantner1, J Bausson2, A Filipputtu2, R Freitag2, B Moulin3, S Caillard3, S Fafi-Kremer4. 1. Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, 3 rue Koeberlé, F-67000 Strasbourg, France; INSERM UMR S1109, LabEx Transplantex, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France. 2. Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, 3 rue Koeberlé, F-67000 Strasbourg, France. 3. INSERM UMR S1109, LabEx Transplantex, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France; Département de Néphrologie et Transplantation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. 4. Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, 3 rue Koeberlé, F-67000 Strasbourg, France; INSERM UMR S1109, LabEx Transplantex, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France. Electronic address: samira.fafi-kremer@unistra.fr.
Abstract
OBJECTIVES: New biomarkers reflecting the degree of immunosuppression in transplant recipients are needed to provide an optimal personalized balance between rejection and infection risks. METHODS: For this purpose, we investigated TTV viremia dynamics in 66 kidney transplant recipients followed up for two years after transplantation, in relation to BK virus infection and graft rejection. RESULTS: After transplantation, TTV viremia rose by ≥2 log10 copies/mL from baseline to month 3, then declined by ≥1 log10 copies/mL thereafter. Higher TTV viremia was associated with recipients of a deceased donor, a lower count of CD8+ T cells and a higher BKV viremia. Importantly, TTV loads were significantly lower in KTR who would later display graft rejection; indeed, patients with TTV viremia lower than 3.4 log10 copies/mL at transplantation or lower than 4.2 log10 copies/mL at month 1 had a higher risk of developing graft rejection in the two following years (hazard ratio (HR) at D0 = 7.30, p = 0.0007 and HR at M1 = 6.16, p = 0.001). CONCLUSIONS: TTV viremia measurement at early times post transplantation predicts graft rejection and would represent a useful tool to improve kidney transplant monitoring.
OBJECTIVES: New biomarkers reflecting the degree of immunosuppression in transplant recipients are needed to provide an optimal personalized balance between rejection and infection risks. METHODS: For this purpose, we investigated TTV viremia dynamics in 66 kidney transplant recipients followed up for two years after transplantation, in relation to BK virus infection and graft rejection. RESULTS: After transplantation, TTV viremia rose by ≥2 log10 copies/mL from baseline to month 3, then declined by ≥1 log10 copies/mL thereafter. Higher TTV viremia was associated with recipients of a deceased donor, a lower count of CD8+ T cells and a higher BKV viremia. Importantly, TTV loads were significantly lower in KTR who would later display graft rejection; indeed, patients with TTV viremia lower than 3.4 log10 copies/mL at transplantation or lower than 4.2 log10 copies/mL at month 1 had a higher risk of developing graft rejection in the two following years (hazard ratio (HR) at D0 = 7.30, p = 0.0007 and HR at M1 = 6.16, p = 0.001). CONCLUSIONS:TTV viremia measurement at early times post transplantation predicts graft rejection and would represent a useful tool to improve kidney transplant monitoring.
Authors: Carter Merenstein; Guanxiang Liang; Samantha A Whiteside; Ana G Cobián-Güemes; Madeline S Merlino; Louis J Taylor; Abigail Glascock; Kyle Bittinger; Ceylan Tanes; Jevon Graham-Wooten; Layla A Khatib; Ayannah S Fitzgerald; Shantan Reddy; Amy E Baxter; Josephine R Giles; Derek A Oldridge; Nuala J Meyer; E John Wherry; John E McGinniss; Frederic D Bushman; Ronald G Collman Journal: mBio Date: 2021-08-17 Impact factor: 7.786
Authors: Rogier As Hoek; Erik Am Verschuuren; Rory D de Vries; Judith M Vonk; Debbie van Baarle; Marieke van der Heiden; Johanna P van Gemert; Edmund J Gore; Hubert Gm Niesters; Michiel Erasmus; Merel E Hellemons; Sandra Mj Scherbeijn; Nynke Wijbenga; Edris A F Mahtab; Corine H GeurtsvanKessel; Coretta Van Leer Buter Journal: J Heart Lung Transplant Date: 2022-03-16 Impact factor: 13.569
Authors: Konstantin Doberer; Martin Schiemann; Robert Strassl; Frederik Haupenthal; Florentina Dermuth; Irene Görzer; Farsad Eskandary; Roman Reindl-Schwaighofer; Željko Kikić; Elisabeth Puchhammer-Stöckl; Georg A Böhmig; Gregor Bond Journal: Am J Transplant Date: 2020-03-08 Impact factor: 8.086
Authors: Vasiliy I Reshetnyak; Igor V Maev; Alexandr I Burmistrov; Igor A Chekmazov; Tatiana I Karlovich Journal: World J Gastroenterol Date: 2020-04-21 Impact factor: 5.742
Authors: Carter Merenstein; Guanxiang Liang; Samantha A Whiteside; Ana G Cobián-Güemes; Madeline S Merlino; Louis J Taylor; Abigail Glascock; Kyle Bittinger; Ceylan Tanes; Jevon Graham-Wooten; Layla A Khatib; Ayannah S Fitzgerald; Shantan Reddy; Amy E Baxter; Josephine R Giles; Derek A Oldridge; Nuala J Meyer; E John Wherry; John E McGinniss; Frederic D Bushman; Ronald G Collman Journal: medRxiv Date: 2021-04-05